The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (143.39) USD. With the latest stock price at 9.30 USD, the upside of Regenxbio Inc based on DCF is -1641.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 7.9% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (306.53) - (95.46) | (143.39) |
| Upside | -3396.1% - -1126.5% | -1641.8% |